November 24, 2022

November 18, 2022

CHEK2 pathogenic germline variants in NSCLC patients

  • Steven Sorscher
Published online: November 18, 2022
100439

Molecular epidemiology and treatment patterns of patients with EGFR exon 20-mutant NSCLC in the precision oncology era: The European EXOTIC registry

  • Giannis Mountzios,
  • David Planchard,
  • Giulio Metro,
  • ...
  • Amanda Psyrri,
  • Martin Reck,
  • Giuseppe Lo Russo
Published online: November 18, 2022
100433

Phase I Study of Ceritinib combined with Trametinib in Patients with Advanced ALK- or ROS1-Positive Non-Small Cell Lung Cancer

  • Matthew S. Lara,
  • Matthew A. Gubens,
  • Bianca Bacaltos,
  • ...
  • Trever G. Bivona,
  • Jonathan W. Riess,
  • Collin M. Blakely
Published online: November 18, 2022
100436

November 9, 2022

Genomic profiling identifies putative pathogenic alterations in non-small cell lung cancer brain metastases

  • Marcin Nicoś,
  • Luuk Harbers,
  • Enrico Patrucco,
  • ...
  • Jacek Jassem,
  • Chiara Ambrogio,
  • Nicola Crosetto
Published online: November 09, 2022
100435

Unexpected cardiotoxicity in HER2-mutant non-small cell lung cancer patients treated with trastuzumab deruxtecan

  • Mariona Riudavets,
  • Arshid Azarine,
  • Sondes Smaali,
  • ...
  • Charles Naltet,
  • Annas Gazzah,
  • David Planchard
Published online: November 09, 2022
100432

November 8, 2022

Brief Report: Clinical Utility Validation of an Automated Ultra-Rapid Gene Fusion Assay for Non-Small Cell Lung Cancer

  • Alessia Buglioni,
  • Patricia L. Caffes,
  • Mark G. Hessler,
  • Aaron S. Mansfield,
  • Ying-Chun Lo
Published online: November 08, 2022
100434

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

  • M.C. Garassino,
  • S. Gadgeel,
  • S. Novello,
  • ...
  • B. Piperdi,
  • M.C. Pietanza,
  • L. Paz-Ares
Published online: November 08, 2022
100431

November 6, 2022

Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer

  • Peter L. Zhan,
  • Maureen E. Canavan,
  • Theresa Ermer,
  • ...
  • Michael F. Kaminski,
  • Kimberly L. Johung,
  • Daniel J. Boffa
Published online: November 06, 2022
100429

Remarkable intracranial response to sotorasib in a patient with KRASG12C-mutated lung adenocarcinoma and untreated brain metastases: A case report

  • Justin Yeh,
  • Jennifer A. Marks,
  • Ali H. Alzeer,
  • ...
  • Peter J. Bergquist,
  • Stephen V. Liu,
  • Chul Kim
Published online: November 06, 2022
100428

October 25, 2022

Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With PD-1/PD-L1 Blockade−Resistant Advanced Non−Small Cell Lung Cancer

  • Marcelo V. Negrao,
  • Vassiliki A. Papadimitrakopoulou,
  • Andrew C. Price,
  • ...
  • James E. Wooldridge,
  • Arthur M. Krieg,
  • Jiaxin Niu
Published online: October 25, 2022
100423

September 26, 2022

In Response to “De Novo KRAS G12C-Mutant SCLC: A Case Report”

  • Margaret Moore,
  • Yuyang Zhuo,
  • Jeffrey D. Mandell,
  • Stephen G. Gaffney,
  • Jeffrey P. Townsend
Published online: September 26, 2022
100418
Advertisement